CAREone Ultra Strength Calcium Antacid Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Guardian Drug Co. Inc. is recalling CAREone Ultra Strength Calcium Antacid chewable tablets due to the presence of small metallic particles.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 9, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, otc-drug.
What Happened
Guardian Drug Co. Inc. initiated a voluntary recall of CAREone Ultra Strength Calcium Antacid due to the presence of foreign substance consisting of small metallic particles in the chewable tablets.
Which Products Are Affected
The recall affects CAREone, ULTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate 1000 mg, 72 chewable Tablets, NDC 72476-178-23, UPC 0341520003516, Lot #: 1716259, Exp 3/31/2029. The product is distributed nationwide in the United States.
What You Should Do
Consumers should stop using the affected product and contact the recalling firm for return or refund instructions.
Why This Matters
Class II recalls indicate products that may cause temporary or medically reversible adverse health consequences.
Source
FDA Recall D-0566-2026 - Retail Business Services, LLC.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (845 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to July 9, 2026.
Frequently Asked Questions
Common questions about this FDA recall.